11:41 - 18.08.2026

---

August 18, Fineko/abc.az. Swiss food giant Nestle is leveraging artificial intelligence and nutritional science to turn the rise of GLP-1 weight-loss drugs like Ozempic and Wegovy into a business opportunity. The company is developing specialized dietary products tailored to millions of consumers taking these appetite-suppressing medications.

To address common side effects of rapid weight loss, such as loss of muscle mass and facial fat (often termed "Ozempic face"), Nestle has integrated collagen protein into its Vital Proteins product line. Chief Technology Officer Stefan Palzer stated that the company uses AI to analyze clinical research and identify nutrient combinations designed to support muscle health, hydration, and essential nutritional intake.